ABC
L’irsutismo
HIRSUTISM
Angela De Cunto, Giorgio Tonini
Clinica Pediatrica, IRCCS Pediatrico “Burlo Garofolo”, Trieste
Settembre 2011 - pagg. 448 -452
Abstract
Excessive hair growth is often a challenge for paediatricians. First of all, hirsutism (defined
as excessive terminal hair growth in women, often with a typical male pattern)
should be differentiated from hypertrichosis. This differentiation is important to decide
for further endocrinologic investigations. This feature begins with a case vignette that highlights
a common clinical problem. Evidence supporting various diagnostic and therapeutic
strategies is then presented.
Classificazione MeSH
Bibliografia
1. Ehrmann DA. Polycystic ovary syndrome.
N Engl J Med 2005;352:1223-36.
2. Rosenfield RL. Hirsutism. N Engl J Med
2005;353:2578-88.
3. Ferriman D, Gallwey JD. Clinical assessment
of body hair growth in women. J Clin
Endocrinol Metab 1961;21:1440-7.
4. Hatch R, Rosenfield RL, Kim MH, Tredway
D. Hirsutism: implications, etiology, and
management. Am J Obstet Gynecol 1981;
140:815-30.
5. American College of Obstetricians and Gynecologists.
ACOG practice bulletin: clinical
management guidelines for obstetrician-gynecologists:
number 41, December 2002. Obstet
Gynecol 2002;100:1389-402.
6. Balsamo A, Cicognani A. Congenital adrenal
hyperplasia due to 21-hydroxylase deficiency.
Medico e Bambino 2005;24:293-301.
7. New MI, Lorenzen F, Lerner AJ, et al. Genotyping
steroid 21 hydroxylase deficiency:
hormonal reference data. J Clin Endocrinol
Metab 1983;57:320-7.
8. New MI. Extensive clinical experience:
nonclassical 21-hydroxylase deficiency. J
Clin Endocrinol Metab 2006;91:4205-14.
9. Rotterdam ESHRE/ASRM-Sponsored
PCOS consensus workshop group. Revised
2003 consensus on diagnostic criteria and
long term health risk related to polycystic
ovary syndrome (PCOs). Hum Reprod 2004;
19:41-7.
10. Van Hooff MH, Voorhorst FJ, Kaptein
MB, Hirasing RA, Koppena Shoemaker J.
Polycystic ovaries in adolescents and the relationships
with menstrual cycle patterns, luteinizing
hormone, androgens and insulin.
Fertil Steril 2000;74:49-58.
11. Avvad CK, Holeuwerger R, Silza VC, Bordallo
MA, Breitenbach M. Menstrual irregularity
in the first years an early clinical sign
of polycystic ovary syndrome in adolescence.
Gynecol Endocrinol 2001;15:170-7.
12. Haedersdal M, Gotzsche PC. Laser and
photoepilation for unwanted hair growth. Cochrane
Database Syst Rev 2006;(4):CD00-
4684.
13. Ibanez L, De Zegher F. Flutamide-metformin
therapy to reduce fat mass in hyperinsulinemic
ovarian hyperandrogenism: effects in
adolescents and in women on third-generation
oral contraception. J Clin Endocrinol
Metab 2003;88:4720-4.
14. Falsetti L, Pasinetti E. Treatment of moderate
and severe hirsutism by gonadotropin-
releasing hormone agonists in women
with polycystic ovary syndrome and idiopathic
hirsutism. Fertil Steril 1994;61:817-22.
15. Arslanian SA, Lewy V, Danadian K, Saad
R. Metformin in obese adolescent with
polycystic ovary syndrome and impaired glucose
tolerance: amelioration of exaggerated
adrenal response to adrenocorticotropin with
reduction of insulinemia/insulin resistance. J
Clin Endocrinol Metab 2002;87:1555-9.
16. Moghetti P, Castello R, Magnani CM, et
al. Clinical and hormonal effects of the 5α-reductase
inhibitor finasteride in idiopathic hirsutism.
J Clin Endocrinol Metab 1994;79:
1115-21.
Corrispondenza: angela.decunto@libero.it